
Medtronic PLC MDT
Quarterly report 2025-Q4
added 02-24-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.29 B |
Market Cap[1] |
$ 124 B |
EBITDA (LTM) |
$ 7.85 B |
P/E (LTM) |
25.59 |
P/S (LTM) |
3.57 |
EPS (LTM) |
3.78 |
Medtronic is an international medical company that specializes in developing and manufacturing innovative medical technologies. The company was founded in the United States in 1949 and today is a leader in the field of medical technology.
Medtronic offers a wide range of products and services in cardiology, endocrinology, neurology, orthopedics, surgery, and more. Among the company's products are implantable cardiac pacemakers, glucose meters, insulin infusion pumps, pain management systems, deep brain stimulation devices, and much more.
Medtronic is actively engaged in scientific research and development in the field of medicine. As a result, its products are the most effective and safe for patients. The company also provides training and consultations to doctors and medical personnel on the use of its products.
Medtronic has offices and representatives in more than 160 countries around the world, which allows it to provide maximum accessibility of its products and services to patients worldwide. Medtronic is a reliable partner for medical institutions and patients who need innovative solutions to maintain health and life.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Bruker Corporation
BRKR
|
$ 39.08 | -1.83 % | $ 5.82 K | Nasdaq Global Select Market,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 7.79 | 3.73 % | $ 559 M | Nasdaq Global Select Market,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.49 | -0.38 % | $ 121 M | Nasdaq Capital Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 9.41 | -2.39 % | $ 1.27 B | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
CONMED Corporation
CNMD
|
$ 43.34 | -5.35 % | $ 1.35 B | NYSE,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.45 | 2.84 % | $ 23.4 M | Nasdaq Global Select Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
IRadimed Corporation
IRMD
|
$ 104.65 | 0.88 % | $ 1.33 B | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 29.78 | -2.84 % | $ 1.37 B | Nasdaq Capital Market,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 3.18 | -3.05 % | $ 110 M | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.52 | -5.19 % | $ 53.4 M | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.53 | - | $ 59.8 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Medigus Ltd.
MDGS
|
- | 10.28 % | $ 55.5 M | Nasdaq Global Select Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.79 | 5.78 % | $ 43 M | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 182.92 | -3.23 % | $ 13.7 B | Nasdaq Global Select Market,SPB | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Inari Medical
NARI
|
- | - | $ 4.23 B | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 3.73 | -3.37 % | $ 790 M | NYSE | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.96 | -3.54 % | $ 148 M | Nasdaq Global Market | ||
|
Abbott Laboratories
ABT
|
$ 113.53 | -0.49 % | $ 198 B | NYSE,SPB | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
Orthofix Medical
OFIX
|
$ 13.02 | -2.62 % | $ 516 M | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 73.88 | -3.07 % | $ 109 B | NYSE,SPB | ||
|
PAVmed
PAVM
|
$ 9.94 | -0.4 % | $ 71.9 M | Nasdaq Capital Market | ||
|
Penumbra
PEN
|
$ 340.23 | -0.61 % | $ 13.2 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.